858-692-3573 info@denovicontx.com

Better Drugs to Market Faster

Denovicon seamlessly integrates AI, machine learning, and molecular modeling approaches (such as quantum chemistry, molecular dynamics, and free-energy methods) into its (hybrid) computational drug discovery platform. With it, a vast amount of chemical space (~1027 molecules) is quickly and accurately triaged, with only the most desirable analogs being identified as hits that are then ultimately transformed into clinical candidates. We are currently focused on small-molecule therapies for oncology and immuno-oncology targets.